Advancing technology in botanical medicine is driving the growth in Global Plant Based Biomanufacturing Market in the forecast period, 2022-2026.
According to TechSci Research report, “Global Plant Based Biomanufacturing Market By Product Type (Antibodies, Vaccines, Proteins, Biologics, Enzyme, Others) By Technology (Upstream v/s Downstream) By Source (Whole Plant, Plant Cells, Seed, Leaf, Others) By End User (Biotechnology & Pharmaceutical Companies, Contract Manufacturing Organizations, Others) By Region, Competition Forecast & Opportunities, 2026”, the global plant based biomanufacturing market may potentially project an impressive growth in the forecast period, 2022-2026, with an impressive CAGR on the account of rising demand for food and beverages containing organic and herbal ingredient. Surging demand from the health-conscious consumers has driven the biotechnological research to be dedicated toward finding such product. Number of biotechnological studies and research institutes are rapidly increasing and thus driving the growth of the global plant based biomanufacturing market in the upcoming five years. Increasing number of upcoming plant-based proteins and development in the studies of recombinant protein that are plant based, is also supporting the growth of the global plant based biomanufacturing market in the next five years.
Plant based biomanufacturing includes protein manufacturing processes through recombinant protein production. These proteins include protein biopolymers, industrial proteins and enzymes, and therapeutic proteins. The production processes involve a narrowing diversity of bioreactors for cell, hairy root, microalgae, and moss cultivation. Direct use of cultivated plant cells, whole or minimally processed plants, or plant parts (e.g., seeds, dried leaves) is in development for industrial/bioenergy applications as well as for therapeutics and vaccines and play a vital role in bio-pharmaceutical productions.
Browse over XX market data Figures spread through110 Pages and an in-depth TOC on “Global Plant based biomanufacturing Market”
The global plant based biomanufacturing is segmented by product type, technology, source, end user, competitional landscape, and regional distribution. Based on technology, the market is further divided between upstream biomanufacturing and downstream biomanufacturing. Upstream biomanufacturing is the process of growing protein products by either bacterial culture of cell culture. Plant cells if used for these cultures are termed as upstream plant based biomanufacturing. These manufactured proteins are specifically laboratory designed to combat various kind of diseases. In the upstream biomanufacturing processes, the biological materials are obtained from outside source or inoculated and grown in culture, under controlled conditions. In the downstream biomanufacturing process the biological products are harvested, tested, purified, and packaged. Plant-based biomanufacturing depending on the recombinant protein processes can either be done through upstream or downstream technology. The advantages of these biotechnological processes is anticipated to drive the growth of the global plant based biomanufacturing market in the upcoming five years.
Holding the major shares of the global plant based biomanufacturing market are Pfizer, Inc., Aimmune Therapeutics Inc. (Nestle), Medicago, Inc., Kentucky BioProcessing, Inc., iBio, Inc., PlantForm Corporation, Ventria Bioscience Inc., Protalix Biotherapeutics, Inc., Planet Biotechnology Inc., Zea Biosciences Corp., among others. Market players are actively involved in the research and technological development in the product developments. The advanced technology has made it possible for the industry to provide excellent services through plant based biomanufacturing. Further advancement would aid the market value and brand establishment in the future five years. New market players may focus on the research and development to provide options that satisfies the consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers & acquisitions and new product developments.
Customers can also request for 10% free customization on this report.
“Asia Pacific region is expected to register a substantial growth with the fastest growing CAGR on the account of rapidly increasing biotechnological research in the countries like India, China, South Korea, and China. The evolution of medical, healthcare, and botanical sciences is also apprehensive of the future growth of the global plant based biomanufacturing market. New drug development, effective diagnostics, nutrient based food are some of the major products of plant based biomanufacturing that will enhance the growth mapping of the market. Consistent research and technological advancement may support the new market players trying to enter the market in the future five years and in their brand establishment,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based Global management consulting firm.
“Global Plant Based Biomanufacturing Market By Product Type (Antibodies, Vaccines, Proteins, Biologics, Enzyme, Others) By Technology (Upstream v/s Downstream) By Source (Whole Plant, Plant Cells, Seed, Leaf, Others) By End User (Biotechnology & Pharmaceutical Companies, Contract Manufacturing Organizations, Others) By Region, Competition Forecast & Opportunities, 2026”, has evaluated the future growth potential of global plant based biomanufacturing and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global plant based biomanufacturing market.